MYELOFIBROSIS (MF)
Clinical trials for MYELOFIBROSIS (MF) explained in plain language.
Never miss a new study
Get alerted when new MYELOFIBROSIS (MF) trials appear
Sign up with your email to follow new studies for MYELOFIBROSIS (MF), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Real-World look at myelofibrosis Drug's impact on spleen size
Disease control Not yet recruitingThis study aims to observe how well the drug momelotinib works for people with myelofibrosis in everyday medical practice. It will follow 93 adults with the condition who are already taking the drug as part of their standard care. The main goal is to see if the treatment reduces …
Matched conditions: MYELOFIBROSIS (MF)
Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New drug trial aims to reverse scarring in bone marrow disease
Disease control Not yet recruitingThis study is testing whether the drug pacritinib can reduce scarring (fibrosis) in the bone marrow of patients with myelofibrosis who also have low platelet counts. Thirty participants will take pacritinib for up to two years, with regular check-ups to see if the drug improves b…
Matched conditions: MYELOFIBROSIS (MF)
Phase: PHASE2 • Sponsor: Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Head-to-Head trial aims to find best drug for tough blood cancer
Disease control Not yet recruitingThis study directly compares two already-approved drugs, momelotinib and ruxolitinib, for people newly diagnosed with myelofibrosis who also have low blood cell counts. The main goal is to see which drug is better at shrinking an enlarged spleen and reducing the need for blood tr…
Matched conditions: MYELOFIBROSIS (MF)
Phase: PHASE4 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New hope for scarred bone marrow: drug trial aims to make transplants safer
Disease control Not yet recruitingThis study is testing whether adding the drug Gecacitinib before, during, and after a stem cell transplant can help people with myelofibrosis, a serious bone marrow disease. The main goal is to see if the drug helps patients survive the first year after transplant without their d…
Matched conditions: MYELOFIBROSIS (MF)
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Stanford tests bold move: stop rejection drug early after transplant
Disease control Not yet recruitingThis study aims to see if it's safe and possible to stop a key anti-rejection medication (tacrolimus) much earlier than usual after a bone marrow transplant. It will involve 50 adults with various blood cancers who receive a transplant from a matched donor. The goal is to reduce …
Matched conditions: MYELOFIBROSIS (MF)
Phase: PHASE1 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 06, 2026 15:37 UTC